ID
21486
Descripción
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Palabras clave
Versiones (5)
- 24/4/17 24/4/17 -
- 25/4/17 25/4/17 -
- 3/5/17 3/5/17 -
- 14/11/18 14/11/18 - Sarah Riepenhausen
- 15/3/21 15/3/21 - Dr. rer. medic Philipp Neuhaus
Subido en
24 de abril de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
German Hodgkin Study Group Study HD16/HD17/HD18 Treatment discontinuation form G6AB
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
Descripción
Therapieabbruchbogen
Descripción
Date of discontinuation
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0011008
Descripción
Reason for discontinuation
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
Descripción
Treatment status
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0749659
Descripción
Further documentation
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0175636
Descripción
Date of completion
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0011008
Descripción
Signature
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519316
Similar models
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C011008 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])